35 Burst results for "Eli Lilly"

"eli lilly" Discussed on WCPT 820

WCPT 820

04:12 min | 5 d ago

"eli lilly" Discussed on WCPT 820

"And other winter surge of COVID is a whole batch of new COVID misinformation, right? Yeah, and Elon Musk is one of those people who feel his money will keep him immune from other people dying due to misinformation. Believe me, someone evil out there who is clever. We'll do a lot more than lose four or $5 billion off of the pharmacy market by putting out a false Eli Lilly at. Okay, the next time they're going to claim, I think I said this. I don't know, it was on another show on a cyber warfare. What if? Someone fills ten or 20 false fema Defense Department, Ukrainian ministry of the interior, you know, blue check websites for 8 bucks each and then puts out a false report that a nuclear bomb is detonated. Yeah. The world will go crazy. Markets will crash. Before anyone will ever figure out that it's true or not, what he has created is the perfect information warfare weapons system. And Twitter was that for a very long time, the Russians weaponized it, figured it out, dictators figured out they could hunt their critics on Twitter. I really am part of the audience that even though I'm going to stay on Twitter because I want to see what the last song is. Yeah. When it goes on. Turn out the lights. The party's over. Yeah, but you know what? I have other platforms too. I know a lot of you want to hear more than the 20 minutes that I spend with you. So, you know, I have a website. We're going to be moving over to substack. And I want to see what happens with Twitter. But there were a lot of good things that come out of there. But I suspect that Elon Musk was hired to destroy Twitter to stop the global criticism of all of the world's dictators. And now it will disperse down the little microsites that will never have the strength of Twitter. Yeah. By the way, I want more than the 20 minutes I get a week of you, which is why I bother you relentlessly and call you. A lot of people don't have access to that, so. Yeah. Malcolm, once again, is someone that's written all of these books about this. Are you surprised or just numb to be suddenly people being surprised that Trump has had dinner with Nazis? Anti semites and all of these people. You talk about Charlottesville. You talk about all of it in your books. And now we're several days later for some Republicans or cautiously, but only because, you know, he's a political loser now, but as you've said, they'll snap right back with him. The minute, you know, they think, oh, the base is still with him. How is this new that he had dinner with Nazis and racists and well, with the news media in their amnesia? Essentially, corporate amnesia, you know, anything Trump did was fun and interesting. But you know, we've revisited this, he's meeting with Nazis thing about 30 times. And how suddenly him meeting with Nick Fuentes was a straight up Holocaust denier. You know, advocated genocide against women. You know, and, you know, a flaming neo Nazi, who was the insane Kanye West in my humble opinion, that man needs a straight jacket. All of these factors are suddenly new because everyone wants a new GD Trump story to get their, you know, their readers excited, including many channels, including ones that I've been a commentator on. Yeah. This is just the malfunctioning of the corporate media. And so when liberals come out and say that, hey, this has been going on for a very long while. That's bias. But when it actually comes up and in harms their party. Then they're going to eventually figure out how to blame this one, Joe Biden. Yeah. Yeah, exactly. Exactly. Joe Biden. You can read all of this. They want to kill Americans. Malcolm nets his latest. And can't wait to hear about Malcolm X dot com and more. I love you and we'll see you next week. All right, take care. There he goes. There goes my sailor. Goodbye. 46 minutes after

Twitter Elon Musk fema Defense Department Ukrainian ministry Eli Lilly Trump amnesia Nick Fuentes Malcolm Charlottesville Holocaust denier Kanye West Joe Biden
"eli lilly" Discussed on Opening Arguments

Opening Arguments

03:16 min | Last week

"eli lilly" Discussed on Opening Arguments

"And I agree with you that, I mean, I think that is the flip side of the last 5 minutes that I would not be so cavalier as to say, I think the dog in the house that's on fire, right? Everything is fine when you have a small handful of multi-billion dollar companies that have unfettered control over how they display information and how that's transmitted to you. It's why I think that the pending Gonzales case is a really, really interesting case because the YouTube algorithm is absolutely 100% radicalizing folks right now. So I don't mean to suggest that it certainly not in Elon Musk's Twitter. Yeah, no, I was just going to say if anything illustrates that point, it's Elon Musk taking over Twitter. So we're not in Twitter we trust. I think those are really good points. I think that there is a kernel of a fair argument. I mean, the Hunter Biden laptop story is the stupidest thing I've ever seen, but nevertheless, like if you ask, should a small number of companies have, is it a good model where the only restraint on that is sort of the capitalist profit motive? And probably not. So a certainly agree that it's worth making sure we talk about that in full count. And I did not know that story. Part of that is just, yeah, no. I went on to do the Hunter Biden laptop move. Yeah, listen to that one. And I know less about what's on Hunter Biden's laptop than I did going into it, right? Well, it's also completely irrelevant to anything. I mean, again, we have even if you took all the facts as stated by the right, Trump put his own family in position to profit. A day one. In front of us. Yeah. Completely in front of us. Like, for all to see, Jared is, you know, getting billions from the Saudis now because of the power that Trump gave him. I mean, it's ridiculous. Kellyanne Conway hawked if hunk is crap from the Oval Office. And then said, oh, what are you going to wait for my handcuffs for the Hatch Act? Yeah. So really responsible reporting on this should be pointing that out every single time. Absolutely. Trump, someone who has helped his family members make billions of dollars off of White House, but inappropriately and against the law as it was previously understood, has accused Hunter Biden of doing drugs or whatever. Recommended that Kellyanne Conway be fired. Yeah. Trump's office of legal counsel said this is as clear a violation of the Hatch Act. It is repeated it is willful. There is nothing that will deter her from continuing to violate the law unless you fire her. And by the way, all we can do is send sternly worded crunchwraps and you appointed us, mister president. Yep. The differing standards is to go back to the beginning point about how much this stuff favors the right. The standards that the media holds the left two versus the right is a major source of that. And it's also just a product of when you're doing scandal after scandal after scandal in plain sight, it's just impossible for the human brain to comprehend that much. Misconduct appropriately, so yeah. But anyway, all right, thanks for the updated two 30 breakdown and I hate you for calling me clarence Thomas forever. That was the whole point. Thank

Hunter Biden Elon Musk Kellyanne Conway Twitter Trump Gonzales YouTube Oval Office Jared White House clarence Thomas
"eli lilly" Discussed on Opening Arguments

Opening Arguments

07:05 min | Last week

"eli lilly" Discussed on Opening Arguments

"Nowhere does this provision protect a company that is itself the information content provider. And an information content provider is not just the primary author or creator. It is anyone responsible in whole or in part for the creation or development of the content. Two 30 F three. But from the beginning, courts have held that two 30 C one, protects the exercise of a publisher's traditional editorial functions such as deciding whether to publish withdrawal, postpone, or alter content. So that is why I say it is just absolutely clear that there's no case against Eli Lilly 69. That decision to publish withdraw postpone or alter by giving a little check mark to Eli Lilly 69 has been held to be at the core of section two 30 C one immunity. Notwithstanding the fact that it technically violates that another part of the statute. And then the third area, this doesn't have really a pithy name to it. I don't think clarence Thomas does a good job of describing it because he's covering up for what they're really mad about, which what Trump and conservatives want. Yeah, conservatives think and truly believe and this is so funny. They think that all of tech is like discriminating against conservative content online when actually the opposite is true. Like any measure that anyone takes of this is like, no, actually they're at a huge advantage. An unearned advantage. But they work the refs, and they've tricked everybody into thinking they're this discriminated against minority. Actually, that's a common theme. You know, whether the persecution complex, whether it's white Christians being the actual victims or, you know, white people in college admissions being the actual victims or conservatives on Twitter being the actual victims. It is a real victim mindset. That's the real motive here. So if you're wondering why you might accidentally be agreeing with clarence Thomas, I think it's because the real reason he's not being straightforward with a real reason, right? Yeah, I think that's right. And Donald Trump, for example, has been very straightforward with the real reason that is you're engaged in viewpoint discrimination against my racist views and that's why you kick me off the platform and not what Donald Trump thinks is his equivalent, which would be somebody like, you know, he missed all or whatever. Not people arguing for affirmative action. They're ranking the races just like I'm ranking the races, right? Yeah, if I say an election was stolen and it wasn't. And you said that's the same. It's saying that it wasn't. And that leads to and I love the fact that you drew the distinction there about the way in which tech companies have actually promulgated and pushed content forward that is 100% radicalizing individuals who absorb that content on the Internet. And one of the things that's come under that most fire that I think rightly so is the YouTube algorithm. If you're on YouTube, like if you just kind of let it go, even if you start off with a good skeptical how to fix my door. Did you mean to search for how to become a Nazi and storm the capitol? No, I didn't mean that. Why did you suggest that? You will get very, very quickly, like I get the suggestions all the time. By the way, use click in the upper right hand corner. If you watched YouTube video, there's a report this video and you can describe it as hate speech, and you should be every time it pops up with a PragerU video. You should be right clicking in the upper right hand corner and describing it as hate speech. I don't know where it goes, but can I say also, this is a separate well, it might be separate. I have realized this is kind of a different thing that I only just now happened to me enough to realize. You may not have noticed, but YouTube search is actually completely worthless now. Have you found that? Not as such. They have ruined it. So if you search for anything, like I'm searching sometimes when I'm doing audio production, I'm just searching for like a how to or I'm searching for a specific whatever video. You get 5 results that are your search, and then it instantly goes to, yeah, but we think we know probably what you'd rather see, and it's never right. It's always nothing. And it used to be on the Internet that you could kind of be like, all right, I'll just ignore that section. YouTube doesn't let you. They only it's like if you did a Google search, which also is getting worse and worse. It's like if you did a Google search Andrew, and they only let you see the first 5 results. And there was no other pages. You're like, but I want to see other results. They don't let you. It's unbelievable. I keep doing it thinking I must be crazy. I must be missing a button or something, but I've searched like, hey, you know, is anyone else seeing that YouTube search is ruined and everybody's like, yeah, it's ruined. You can't even use it anymore. Unbelievable. With that in mind, I don't know what to say about this old man screams at cloud about the YouTube search, but no, I'm about to transition. Into the Gonzales versus Google case, which involves the YouTube algorithm. Here's the inciting incident in November 2015, no him Gonzalez a 23 year old U.S. citizen studying in Paris. She was murdered when three ISIS terrorists fired into a crowd of diners at la Belle equip bistro in Paris. That was part of a broader series of attacks by ISIS in Paris, which included several suicide bombings and a mass shooting, miss Gonzalez was one of a 129 people killed. During those events, when the hell was this? November 2015 in Paris. So the complaint alleged that assistance and aid to the ISIS mass shooting took several forms, including that Google had knowingly permitted ISIS to put on YouTube hundreds of radicalizing videos inciting violence and recruiting potential supporters to join ISIS forces than operating in the Middle East. And to conduct terrorist attacks in their home countries. Additionally, and at the core of the appeal, the complaint alleged that Google affirmatively quote recommended ISIS videos to users via the algorithm. Google selected the users to whom it would recommend ISIS videos based on what Google knew about each of the millions of YouTube viewers targeting users whose characteristics indicated that they would be interested in icebergs. Satire of our time would be that actually Google and all these companies have an advertising profile that actually just has a tick box that's like going to be a terrorist? Yes or no. And they actually know that before any authorities do. It might be literally true actually. Probably predict terrorism. Almost certainly is literally true. Yeah. Show them the terrorist supply ads because they're going to need them. The selection of users to whom ISIS videos are recommended was determined by computer algorithms created and implemented by Google.

YouTube Eli Lilly clarence Thomas Donald Trump Google Trump Paris ISIS Twitter la Belle equip bistro Gonzalez Gonzales Andrew U.S. Middle East
"eli lilly" Discussed on Opening Arguments

Opening Arguments

04:30 min | Last week

"eli lilly" Discussed on Opening Arguments

"And you would have to exclude the fact that in the week beforehand, Twitter said, no, we're going to get rid of doing the work and we're just going to allow you to buy it, which would be a pretty good defense if your Twitter. But there's also the second half of the protection. So the first half says, we don't treat you as the speaker. The second half says that no provider or user of an interactive computer service shall be held liable on account of a any action voluntarily taken in good faith to restrict access to or availability of material that the provider or user considers to be obscene, lewd lascivious filthy excessively violent, harassing or otherwise objectionable whether or not such material is constitutionally protected, but a pin in that. Or B, any action taken to enable or make available to Internet content providers or others, the technical means to restrict access to material described in paragraph one. I just described. This makes sense. So it's like they don't want to make it such that if someone makes an effort to filter their stuff a bit, that would open them up to liability, and therefore disincentivize anyone from making any effort. That's exactly 100% correct. And that's why it includes that language, whether or not such material is constitutionally protected. The idea, the thought process here was, hey, we want to make sure that little Johnny can't see boobies and just let little Johnny see boobies. Come on. And so we want to incentivize AOL to have a series of filters that prevent you from seeing boobies, and we don't want anybody to be able to sue them in connection with that decision if they are overly broad in censoring the amount of boobies you can see or whatever, right? That's why you had that very broad language. And again, most of it is porn oriented. Obscene lewd lascivious filthy. Excessively violent, harassing, or otherwise objectionable, and it clearly also and there's testimony in the congressional record, applies to hate speech. We wanted the definition of hate speech as you and I have talked about since OA episode one is very, very narrow. I can say hateful horrors we've seen over the past 6 years, you know, the far right can say hateful, horrible, neo Nazi racist crap. And unless it is imminently likely to lead to the incitement of actual violence, it doesn't get restricted. Yeah, because we never want to allow little Johnny to be able to see boobies. But we do want him to have the ability to be radicalized by online Nazis as much as possible. That's where our priorities are. Again, section two 30 airs on the other side, groups that together and says, yeah, we also want to make sure that if a content provider is restricting hate speech, that that not be an argument that's available to them, right? That, hey, it's my constitutional right to think that, you know, to rank the races on AOL dot com. And no, no, it doesn't matter whether it is or it isn't. No liability will attach to any provider who voluntarily in good faith restricts access to your hateful crap out of an idea to protect against material that is harassing or otherwise objectionable, whether or not such material is constitutionally protected. So meant to be broadest possible protections to encourage self regulation and self restriction in this area. And when you read both of those in context, it is very, very clear that the history, the broad history of section two 30 decisions would extend to, even if there was an argument that Twitter is itself speaking when it puts the little check mark on there and you may have noticed that C one says no provider or publisher of any interactive computer service shall be treated as the publisher or speaker of any information provided by another information content provider. And so you might raise the argument of, hey, no, this is not another, right? This is Twitter putting a check mark on Twitter, so they're the same information content provider doesn't matter case law is super clear that that another has been effectively read out of the statute. It's been interpreted broadly as including speech engaged in by the interactive computer service at the time.

Twitter Johnny AOL
"eli lilly" Discussed on The Secret History of the Future

The Secret History of the Future

08:21 min | 2 weeks ago

"eli lilly" Discussed on The Secret History of the Future

"And we're back. So Helen Lewis recently wrote a piece for the Atlantic and I'm going to read a quote from it. And I want you to react to this quote. Twitter Musk is the price we pay for SpaceX Musk and Tesla Musk. At least he's honest about the human cost of his ambition. Give me one honest Elon over a thousand tech unicorns waxing pies about saving the world. Discuss. How does this make you feel? That Helen Lewis needs to learn how to use Google. Say more. Maybe that's too harsh, but I'm sorry, I just totally disagree. I mean, I think that Elon Musk has certainly positioned Tesla as, you know, a company that helps alleviate climate change. If you look at Tesla, if you look at SolarCity, if you look at Tesla's impact report in 2020, I just pulled this up to Tesla customers helped accelerate the world's transition to sustainable energy by avoiding 5 million metric tons of CO2 emissions. I also have a very distinct memory of interviewing like a sort of prominent tech booster. Many, many years ago, 2015. Telling me I drive a Tesla, I'm saving the world. So I just don't think that's true that he hasn't positioned himself that way. And as we have just discussed, any time there is a high profile opportunity to swoop in and save somebody the world, the boys in the Thai cave, people with COVID, he takes it. He may not complete that mission, but he certainly takes it. So I think that's absurd. I also think that maybe SpaceX and Tesla, you know, are they interesting successful companies? Absolutely. Have they done good stuff? Absolutely. But like, are they astonishingly revolutionary? I don't know. I feel comfortable saying no. I mean, SpaceX is basically the U.S. based program right now, and it is a massive government contractor. That's a lot of money coming from coming from the U.S. government, and they have done some incredible stuff with rocket technology, but I don't know. This idea that he is a genius inventor is not correct. He doesn't make the proprietary technology himself, does he? No, and these companies have done, I mean, I think actually maybe the coolest thing is what Tesla has done with batteries. That is, in fact, cool. But. The thing that he is good at is this thing we talked about of like identifying where a hole in the market is and how to position his company to fill it. And that is a genuine talent, but it is not a, you know, Albert Einstein like thing. His desire to make humanity a multi planetary species does not strike me as altruistic. And it strikes me more as colonial. If I must say so myself. My next question is about stocks, which I don't understand at all. Did Twitter actually cause a decline in the stock prices of the pharmaceutical company, Eli Lilly and Company because it verified account that was purchased through Twitter blue, tweeted that insulin is free now. It seems, it seems that way. What I don't, you know, the stock did plunge. And it took quite a while to work its way back up. What was not clear to me was whether the stock plunged because some panic trader saw that, or somebody saw that and thought, oh, dum dums are gonna sell, so let's short Eli Lilly stock and make that a play. Or another choice might be that somebody saw that, thought, oh, that's embarrassing. Yeah, insulin really shouldn't be priced where it is. You know what? Let's sell because there's some reputational risk associated with Eli Lilly just at this moment. And then maybe we'll buy it back in a couple days. Yeah, I can't say I feel bad for Eli Lilly, but I must say I actually thought this was pretty funny, but it does seem like bad for companies that perhaps want to advertise on Twitter. They're not doing that now. One could just make a fake cheez its Twitter and say, we are now putting ants in our cheez its for a new source of protein or chiquita banana, we have overthrown the government of Brazil, which was my personal favorite. That was phenomenal. And then just kidding, we haven't done any coups since 1954. Which true? It's not a lie, yes. So far, at least in terms of what we've talked about, has not done a single good thing since this purchase of Twitter that I can besides giving us endless content. It's a great question. Have I missed something? I mean, I'm sure I should come up with something. There is an argument that a lot of tech companies, Twitter among them, over hired. Because in engineering, it's good to have a deep bench, right? To be able to make the next cool thing. And it's not totally shocking that he would come in and say, there are too many people here. If we're still a public company, that's probably something that investors would like. But it's not. You know one thing I will actually say this for the $8 verification idea. Twitter needs to make some money. It's not the worst thing in the world to have someone coming up with ideas to make money. Um. Force for the trees type situation where maybe the trees of $8 I can pretend to be chiquita banana actually lost you the forest of advertisers. But coming up with ideas for a money losing product to make money, that's actually something a CEO should be doing. Yeah. There, I did it. I did it, Rachel. Did it. Honestly, congratulations. You're nicer than I am. Just try to see all the subtleties. That's fair. I see things in black and white. Why does this man have such a large fandom? Why do so many people like him? Why are so many people and I would say pardon my language, but this is my shit. Why are so many people dick riding for this man? I don't get it. I don't understand. Because the myth of the singular tech genius is very, very hard to kill in America. I also think it's tied up with cars on rockets, like it seems really cool. These things seem cool. I actually have never fully understood the rabid Musk fandom. Which is often on display in my replies. I'm just like. Also, you know what? People love money. He's really rich. People love money. That is true. That is. It might be that simple. I just have never met a more rabid fandom, and that is really saying a lot, 'cause I've spent a lot of time looking at fandoms, and none of them, I think, approach the level that must does. And I don't even know if they have a name for themselves. I also think there's something about him where he's right on the line of inhabits a space where it perhaps a slightly agreed straight white guy who wants to say a little more outrageous stuff. Feels like emboldened by an Elon Musk. And sees a champion in him. Not totally unlike Joe Rogan's fandom. Oh God. But seeing themselves as a more intellectual version. Of Joe Rogan's

Tesla Helen Lewis SpaceX Twitter SolarCity Elon Musk Elon Eli Lilly Eli Lilly and Company Atlantic U.S. government Albert Einstein Google U.S. Brazil chiquita Rachel dick
"eli lilly" Discussed on WTOP

WTOP

03:45 min | 3 weeks ago

"eli lilly" Discussed on WTOP

"Pay to be verified on Twitter is that the whole point of the procedure was to help users know what was real and what was fake. And what a lot of people had been concerned about turned out to happen, which is that a lot of people paid to get check marks and then pretended to be someone else. So one of the more infamous examples is the pharmaceutical company Eli Lilly tweeted out that they were going to make insulin cheaper free that actually appears to cause its stock to frock, which is a terrible situation for investors, of course, we did a whole other questions as to whether or not that should be a thing that causes shareholders to get concerned. But basically unleashed chaos. And the feeling began on Twitter began to feel like the substitute teacher couldn't control the classroom. It was impossible to know what was real, what was fake. I will tell you my job as a journalist is know what it feel and what it's fake. I got caught a couple of times thinking something was real, which is, you know, to us to say by the end of the day, you know, Elon realized that it wasn't working and he caused it. So it's just been a constant iteration upon iteration about how to handle this blue check program, which has just been a massive headache and a confusing exercise for all. Well, has that program opened up Twitter to possible legal action? I mentioned Eli Lilly's stock dropping. And I'm making this up, but could shareholders too, right? If a stock drop because they're allowed to do something that become cause for a suit and another thing that is also happened this week is Twitter lost a number of top employees, including in its compliance unit. The day before Twitter was set to submit a report to the Federal Trade Commission as part of its agreement with the FTC over this consent decree that they had signed with them for violations several years back. And the FTC actually came out and said that they were concerned and they said they were watching. There were concerns that if there's not sufficient focus on the products and the rollout and the people with the expertise to do that, then Twitter could possibly be in a situation where it's not protecting user privacy and potentially in violation of its agreement with the FTC and that could lead to fines. Or other potential actions. So there is a lot of noise and a lot of concern and a lot of uncertainty right now over at Twitter headquarters. And in that meeting, Musk said that the B word, bankruptcy, not out of the question, goodness. Goodness, you know, usually company, CEOs will try to avoid using the B word until the very last moment. In fact, even when they file for bankruptcy, they will choose to say we signed an agreement with their creditors for a better future. That is not the approach that Elon's hook and everyone. Today has spoken to two to 5 different theories as to why he chose to go there, you know, Elon likes to be a savior. He did that at Tesla. He would use a B word I didn't say that he kind of saved Tesla. So was it just as a savior? Is it to scare the employees to work harder? Is he just trying to upset the banks that have lent him about 13 billion in debt to finance his deal? Is he really concerned that the company could actually go bankrupt? It took on 13 billion in debt. It has 1 billion in interest payments. Is he looking at the cash flow and freaking out? You know, who's to know we have certainly

Twitter FTC Elon Eli Lilly headache Musk Tesla CEOs
"eli lilly" Discussed on WTOP

WTOP

02:00 min | 3 weeks ago

"eli lilly" Discussed on WTOP

"Is what is apparently going on with their process for verifying those accounts. You know those blue check marks that mean on the account is verified and there's a real person of note behind it somewhere? Well, Elon Musk is apparently decided now that anyone can buy that check mark for 8 bucks a month. As you might imagine, there have been plenty of impostor accounts popping up now. This morning to flush this out, we turn to see that editor at large, Ian sure, with more for us. Part of the problem is that Twitter does not really have a communications department anymore. After Elon Musk fired pretty much half the staff, he reduced the communications department reportedly down to two people down from dozens. And the indications are that those two are gone now too. So honestly, it's hard to tell what they're thinking. But at the moment, it seems as though every once in a while we'll see a pop up like one that pretended to be the pharmaceutical giant Eli Lilly that put up a tweet that said, it had a verified thing on it and it was lily's logo and everything. And it said that all insulin was going to be free from now on. Wow. Which wasn't true. And suddenly, their value on the stock market dropped like $20 billion. Because people thought it was real. Yeah, so this is not just sort of jokesters and impostors. This can have a real world. Yes, my laughter is gallows humor at this point. It's crazy what's going on. And the reality is that unfortunately, I mean, we're seeing this happen all over the place. Even Tesla itself there are people who've actually bought accounts, paid the $8 to Twitter to be able to get a verified check mark. And then pretend to be Tesla. And said stuff like they're going to recall all their cars. I mean, it's unbelievable that this is even happening. In the 30 seconds, we have left. If people start leaving Twitter, where will they go? Nobody knows. I mean, that's part of the other thing. The options are pretty limited. No one in my circle of Friends has said, hey, let's go to Facebook. So

Elon Musk Twitter Ian Eli Lilly lily Tesla Facebook
"eli lilly" Discussed on CNBC's Fast Money

CNBC's Fast Money

02:41 min | 2 months ago

"eli lilly" Discussed on CNBC's Fast Money

"Much. Check out shares of Eli Lilly getting a healthy boost higher today, UBS upgrading the stock to a buy saying the weight loss drug could be the biggest drug ever. The bestselling drug in history, it said in the note. It's our call of the day, one of our traders says this could be the Holy Grail for weight loss. Karen, you loved everything about this call. Yes, I did. I loved everything about this call. I am long Eli Lilly. I'm also long novo Nordisk, which makes a competitive product that is on the market. I mean, this is not a hidden secret, right? To hepatitis is supposed to be a gigantic drug either as a diabetes drug and as a weight loss drug under a different name, same thing, basically. So what the basis of the piece was, this will drive lily and that the revenue guidance should be much higher than where it is right now. $25 billion is what they were thinking. And so they put a big multiple on it though. I will say, they do put a big multiple on it to get to that pretty high number. I don't know if it'll get there, but I think this is the kind of thing where you buy the rumor and we're not going to see the drug widespread until next year. But I mean, it's an amazing product when you think about 21% average body weight loss. That is enormous with very few side effects and very positive diabetes reversals, that's staggering. Plus they have some other drugs, Alzheimer's. I don't really count that in the story, but this drug is the Holy Grail. And so I think buying it in front of the release and maybe selling it on the release, but we'll see that early next year. Yeah, the analysts also make the point that the Alzheimer's drug, while it could be promising, is not at all within the model, and it would be sort of like a kicker down the road if it actually was effective but what do you think of the lily? Yeah, I mean, there's really no argument in terms of the valuation. It is expensive, but really when you start to drill down into the numbers, if you look at 25 billion, you look at 20% in that margin. You look at shares outstanding. They get to about $5 a share. And that's before kind of slapped in the multiple on there. And if you look at the penetration that they would need in order to achieve these numbers, their predicating their guidance on about like a one to 5% penetration in terms of obesity cases. So while it is aggressive from evaluation standpoint, the underlying assumptions going in are relatively conservative and I do think that makes for a compelling case. All right, coming up, getting blocked. Shares of the payment company sinking as analysts lose interest in the move is option traders piling in. We got the details next and throughout Hispanic heritage month, we are celebrating our CNBC teammates and contributors.

Eli Lilly novo Nordisk Alzheimer's UBS diabetes Alzheimer's drug hepatitis Karen obesity CNBC
Governor DeSantis Condemns Biden's Haphazard Decision to Revoke Monoclonal Antibody Treatments

The Charlie Kirk Show

02:21 min | 11 months ago

Governor DeSantis Condemns Biden's Haphazard Decision to Revoke Monoclonal Antibody Treatments

"Governor desantis condemns Biden administration's haphazard decision to revoke authorization of lifesaving monoclonal antibody treatments. Governor Ron DeSantis is demanding that the Biden administration reversed its sudden and reckless decision to revoke emergency use authorization. For Regeneron, an Eli Lilly monoclonal antibody treatments. This abrupt and unilateral action by the Biden regime will prevent access to lifesaving treatments for floridians and Americans. The story is this FDA restricts use of two monoclonal antibody treatments. I know people's lives who are saved by monoclonal antibodies. Now, their argument is like, well, it's not working that well against all Macron. Well, if not working that well as the standard for revoking, emergency use authorization, then maybe you should pull some EUA permits for vaccines. Not working that well. First of all, there's no clinical data to support that. Second of all, there is massive momentum amongst doctors action on the front lines of how monoclonal antibodies help condition the response and help with Regeneron regenerating white blood cell treatment and they are lifesaving in some cases. Not all the antibodies are effective. It doesn't work all the time, which is why you need to throw the kitchen sink at it. With all the other treatments, but now the federal government is coming out and they're saying nope, not happening. You are not allowed to use monoclonal antibodies. We are going to get in the way of what doctors are able to do with their patients. Now, we've already used all the words on this show. We know that Joe Biden has no concern whatsoever for the mounting deaths preventable deaths of people that have died from COVID-19 isn't care about the 100,000 plus overdose deaths. But what does he care about then? What is the explanation for this? Well, the FDA justification is they say, well, it's unlikely to be active against the Alma cron variant. Oh, unlikely. Not that it doesn't work, not that they have clinical data to show that monoclonal antibodies are doing harm. No, just that it's

Biden Administration Governor Desantis Governor Ron Desantis Regeneron Eli Lilly Biden FDA Covid Federal Government Joe Biden
DeSantis blasts FDA for halting drugs ineffective on omicron

AP News Radio

00:53 sec | 11 months ago

DeSantis blasts FDA for halting drugs ineffective on omicron

"The the the the by by by by the the the the administration administration administration administration and and and and Florida's Florida's Florida's Florida's Republican Republican Republican Republican governor governor governor governor are are are are in in in in a a a a fight fight fight fight after after after after federal federal federal federal health health health health regulators regulators regulators regulators block block block block the the the the use use use use of of of of two two two two coronavirus coronavirus coronavirus coronavirus antibody antibody antibody antibody treatments treatments treatments treatments the the the the FDA FDA FDA FDA says says says says the the the the drugs drugs drugs drugs from from from from Regeneron Regeneron Regeneron Regeneron and and and and Eli Eli Eli Eli Lilly Lilly Lilly Lilly are are are are not not not not effective effective effective effective against against against against the the the the Omicron Omicron Omicron Omicron variant variant variant variant so so so so it's it's it's it's moved moved moved moved to to to to revoke revoke revoke revoke their their their their emergency emergency emergency emergency authorization authorization authorization authorization the the the the drugs drugs drugs drugs were were were were the the the the centerpiece centerpiece centerpiece centerpiece of of of of governor governor governor governor Rhonda Rhonda Rhonda Rhonda Santa Santa Santa Santa since since since since coronavirus coronavirus coronavirus coronavirus response response response response as as as as he he he he resisted resisted resisted resisted vaccine vaccine vaccine vaccine mandates mandates mandates mandates and and and and other other other other measures measures measures measures people people people people have have have have a a a a right right right right to to to to access access access access these these these these treatments treatments treatments treatments and and and and to to to to revoke revoke revoke revoke it it it it on on on on this this this this basis basis basis basis it's it's it's it's just just just just fundamentally fundamentally fundamentally fundamentally wrong wrong wrong wrong and and and and we're we're we're we're going going going going to to to to fight fight fight fight back back back back at at at at the the the the White White White White House House House House let's let's let's let's just just just just take take take take a a a a step step step step back back back back here here here here just just just just to to to to realize realize realize realize how how how how crazy crazy crazy crazy this this this this is is is is a a a a spokeswoman spokeswoman spokeswoman spokeswoman Jen Jen Jen Jen Psaki Psaki Psaki Psaki says says says says the the the the government government government government has has has has said said said said states states states states including including including including Florida Florida Florida Florida drugs drugs drugs drugs that that that that do do do do work work work work yet yet yet yet to to to to Santos Santos Santos Santos is is is is advocating advocating advocating advocating for for for for treatments treatments treatments treatments that that that that do do do do not not not not Sager Sager Sager Sager made made made made Ghani Ghani Ghani Ghani Washington Washington Washington Washington

Florida FDA Administration Administration Regeneron Regeneron Regeneron Eli Eli Eli Eli Lilly Lilly Li Rhonda Rhonda Rhonda Rhonda Santa Santa Santa Santa Coronavirus Coronavirus Corona White White White White House Jen Jen Jen Jen Psaki Psaki Ps Government Government Governme Santos Santos Santos Santos Sager Sager Sager Sager Ghani Ghani Ghani Ghani Washin Washington
Omicron may sideline two leading drugs against COVID-19

AP News Radio

00:55 sec | 1 year ago

Omicron may sideline two leading drugs against COVID-19

"For for more more than than a a year year and and a a body body drugs drugs from from Regeneron Regeneron and and Eli Eli Lilly Lilly have have been been the the go go to to treatment treatment for for early early covered covered nineteen nineteen but but both both drugmakers drugmakers recently recently warned warned that that lab lab testing testing suggests suggests their their therapies therapies will will be be much much less less potent potent against against Omicron Omicron and and while while the the company company say say they they can can quickly quickly develop develop new new Omicron Omicron targeting targeting antibodies antibodies those those aren't aren't expected expected to to launch launch at at least least for for several several months months that's that's what what Dr Dr Anthony Anthony Fauci Fauci said said on on ABC ABC this this week week with with George George Stephanopoulos Stephanopoulos it's it's a a very very complicated complicated synthetic synthetic process process to to make make the the drug drug it it is is not not something something that that simple simple so so the the company company is is revving revving up up and and getting getting more more and and more more but but we're we're not not gonna gonna see see widely widely available available for for at at least least a a few few months months the the CDC CDC says says the the delta delta variants variants still still accounts accounts for for more more than than ninety ninety five five percent percent of of the the estimated estimated US US cases cases but but agency agency leaders leaders say say Omicron Omicron is is spreading spreading faster faster than than any any past past variants variants and and will will become become the the dominant dominant strain strain nationwide nationwide within within weeks weeks I'm I'm Shelley Shelley Adler Adler

Regeneron Regeneron Eli Eli Lilly Lilly Omicron Omicron Dr Dr Anthony Anthony Fauci Fa George George Stephanopoulos S ABC CDC United States Shelley Shelley Adler Adler
"eli lilly" Discussed on WGN Radio

WGN Radio

01:58 min | 1 year ago

"eli lilly" Discussed on WGN Radio

"Kind of price and you are informed that that price is artificially inflated and you shouldn't have to be deciding whether not to pay for granny's heart medication or the monthly rent when it doesn't have to be that way That would motivate me to vote and of course I don't need motivation I vote every time anyway but if let's say I were a marginal voter that would get me to the polls I agree And I think that's why I'm excited to be on your show talking about this because I just think the average consumer when I talk to consumers most of them have never heard of a pharmacy benefit manager When they think big pharma they think manufacturers and they're the enemy When these pharmacy benefit managers if you look at insulin as a quick example of how they're impacting the system and what they're doing is saying yes the drug could be on the formula It could be on the drug list for your health plan And here's what your co pay is and a little bit more but not a ton And if you look at insulin they're adding your health plan today for humalog Eli Lilly makes you a lot of most commonly prescribed insulin and it's just an easy example for me to pull out of my mind Your plan is paying about $550 a month for that 330 of it is being added in fees by these pharmacy benefit managers 60% of the total their whole reason for existing was to help us make sure the consumer would get a good value Obviously we're very far off track when they're adding 60% to the total cost and they're supposed to be there to get us value We'll come back and we'll talk some more about that with our guest Paul seegert managing partner of PCS advisers and healthcare consultant and we'll be back hello there This is not king Cole wishing you all a happy and a Merry Christmas Is in the giving so let's give lots.

pharma Eli Lilly Paul seegert PCS king Cole
"eli lilly" Discussed on WABE 90.1 FM

WABE 90.1 FM

05:16 min | 1 year ago

"eli lilly" Discussed on WABE 90.1 FM

"Who supervised the development of this drug and then once the FDA gave its approval there was huge follow up What happened within the FDA and among its advisers and a Biogen It became a debacle There was just scientists and people who follow regulatory science who were very upset at the FDA for what it perceived the erosion of the standard The FDA is often considered the gold standard And this appeared to them like potentially opening the floodgates for treatments that may not work at all and will undoubtedly be expensive to be available to patients and there can be great consequences to that Then you have Biogen's decision to set a price for the drug that they say would average out to about $56,000 a year per patient This was you can imagine in raging to people who are already sensitive about drug prices But likewise investors on Wall Street were expecting Biogen to charge somewhere around 10,000 to $15,000 for the drug And also we should say insurance companies many of them declined to reimburse for it and a lot of doctors are refusing to prescribe it There's one other person that I want you to bring in here And we're skipping over a lot of the story We will post it though But this is the CEO Michelle von Usos who was very much an admirer and supporter of Al sandrock the scientist who were talking about here What was going on very briefly behind the scenes between the two of them once the FDA approved very controversially this new Alzheimer's treatment So just as adre helm proved to be a breaking point of public perception of Biogen likewise it ended up straining relationships inside the company So as all of that negative press was heaped on them all of the criticism over the price and then maybe most importantly the really really disappointing financial returns of the company there began to be sort of a game of musical chairs as to who was going to take the blame for this What our reporting has led us to understanding And so cut to November there is the shocking announcement that Alexandra will be retiring effective the end of this year What we learned is that he was pushed out that he was kind of made to bear the brunt of this because the reaction was so polarizing that there was a perception that someone needed to be the face of what is a PR failure on this company's behalf And so the way people characterize it to us was it was going to be not so sandrock And sandrak was on the losing end And at the same time though Biogen is also working on another potential Alzheimer's treatment that's in late stage development There's a lot riding on that one How has Biogen's ignominious experience affected other biotechs working on Alzheimer's drugs has had a chilling effect Has it made them more ambitious or less It's interesting because Eli Lilly the massive pharmaceutical company has a treatment that works somewhat similarly to add your home It's a different drug in late stage development And their stock price is actually gone up much much more than Biogen has in light of the approval of agile because there's a perception among some people that they might be able to step in as you home did the blocking and tackling Now the FDA has agreed to approve these kinds of medicines And Eli Lilly might step in with a conceivably better but at least a drug with less baggage than this one And so the industry might march on and make a great deal of money based in large part on Biogen's pioneering research and Biogen's efforts to win over hearts and minds at the FDA And so the legacy of agile may be that it did indeed open a floodgates but that Biogen itself didn't manage to actually profit from it And based on what we've seen so far and will likely see in the coming months we'll actually be punished for this work that they've done Damian garde is a BioTech reporter for stat thanks to Amy Thanks for having me Biogen had no comment on the Steph's story or on the potential layoffs will link you to Damien's story written with Adam feuerstein at here and now dot org And you're listening to here and now On this Monday afternoon I'm member supported 90.1 Atlanta where ETL meets in PR I'm Jim beris It has been quite the year for the Atlanta Braves and the Atlanta region and today we're kind of paying homage to that when we tell you that when you give to W ABE as part of the fundraiser that we're under in then we're going to enter you into a very special giveaway We're calling it the braves experience And of course your gift also helps to cover the cost of here and now and all things considered which is coming up next And with more on how you can get in on this very special incentive is Jamie green multi platform senior producer Jamie it's wonderful to have you here Oh it's a pleasure to be here with you And so as you may know the Atlanta Braves just had their first World Series title in 26 years That's a long time Jen It's a minute I like that And we wanted to do something special So we reached out to them and they generously offered this incentive and hopes to get you to make that gift of support right now as we wrap up 2021 and look ahead to 2022 This exciting brace package includes.

Biogen FDA Alzheimer's treatment Michelle von Usos Al sandrock sandrock sandrak Alzheimer's Eli Lilly Alexandra Damian garde Amy Thanks Adam feuerstein Atlanta Braves Jim beris Atlanta Steph Damien
US OKs New Use for Eli Lilly’s COVID-19 Treatment

AP News Radio

00:55 sec | 1 year ago

US OKs New Use for Eli Lilly’s COVID-19 Treatment

"Federal regulators have approved a drug from Eli Lilly as a preventative medicine against Kobe eight nineteen it's a new use for Eli Lilly's monoclonal antibody drug combination bam bland never mad but and at a seven map previously authorized as a treatment for high risk patients who had contracted cobit nineteen now under an emergency use authorization the medicines can be used to prevent disease in people who have been recently exposed to the virus age twelve and over earlier this summer a similar drug made by competitor Regeneron was authorized for preventive use antibody drugs are one of the only treatments proven to reduce the risk of death from Kobe nineteen demand for those drugs has boomed as the delta variant has sent cases searching Jackie Quinn Washington

Eli Lilly Bam Bland Regeneron Kobe Jackie Quinn Washington
The Real Cause of Alzheimers and Dementia

Broken Brain with Dhru Purohit

02:05 min | 1 year ago

The Real Cause of Alzheimers and Dementia

"Wanna jump right in and talk about alzheimer's because you wrote a really interesting instagram post. I think it was a few weeks ago. And you were saying. Alzheimer's reversal is is real. It's not just a theory and you were hinting at a new study. Small one but something exciting. That came across your desk that you wanted to highlight and make your audience aware of so. Why are you excited about the study. And what did they cover inside of there. Well i'm hoping you'll share that study with a link. This is work that i've been aware of actually for quite some time. I know you know dr. Dale br edison and he recently published a book. Called the end of alzheimer's. The plan in the first book was invalid. And this one is the plan and i. I wrote the forward to that book and in that ford. I think it really did capture my excitement about the work that he's doing even be beyond how he's broken the mold beyond alzheimer's and let me explain in a. We live in a world where we try to really pigeonhole are diseases to think that they are caused by one thing and therefore we can fix them with a remedy and there's such an effort underway to Find an alzheimer's drug that works just last month. Eli lilly announced the results of a trial. In which they're monoclonal antibody mab was found to reduce the rate of decline of alzheimer's basis by an astounding thirty two percent When they made that announcement the stock value went up. I think twenty billion dollars. Eli lilly but what does that mean. It means. it's slow the decline by third means. People are still declining going to get worse than we know where it ends up generally So it really wasn't a stabilizing alzheimer's or can you imagine actually improving their situation. Because they're looking at one thing. This is a monoclonal antibody that is targeting the so called beta amyloid protein. That's absolutely the cause of alzheimer's.

Alzheimer's Dale Br Edison Alzheimer's Drug Eli Lilly Ford
"eli lilly" Discussed on AP News

AP News

02:09 min | 1 year ago

"eli lilly" Discussed on AP News

"Say the building's roof was being work done, but it's not yet determined if that was a factor in the collapse. I'm Jackie Quinn. The EBS Terry Spencer is in Surfside, and he's been talking to residents in the area. People who were in neighboring buildings described hearing What sounded like either thunder feeling what felt like an earthquake. One said It felt like a a large windstorm income. Many of them check their weather apps on their phone, thinking that they were storm. But they didn't see anything. AP correspondent Terry Spencer in Surfside, Miami Dade's police director says These are difficult times and things are going to get more difficult as we move forward, he says. Former Minneapolis police officer Derek Show Vin will be sentenced today in the murder of George Floyd. Here's our Shelley Adler. Prosecutors are asking for a 30 year sentence, while defense Attorney Eric Nelson wants probation. Vice President Kamala Harris visits the border. Today she'll be in El Paso, Texas. She's been taking heat from members of both parties for not visiting the border with Mexico. Yet this is a P news. Eli Lilly has a potential new Alzheimer's drug. Now it'll asked the FDA to approve it. Drugmaker Eli Lilly said Thursday it plans to submit a possible Alzheimer's drug for approval to the Food and Drug Administration later this year. The Indianapolis based company said it will seek FDA approval for dawn on a map based on results from a mid stage clinical study involving 272 patients with an early form of Alzheimer's researchers said Don't Nana mob showed signs of slowing a decline in cognition and daily function for Patients who took it compared to patients who took a placebo or fake drug. Earlier this year, the FDA approved a new home A treatment from drugmaker Biogen over warnings from independent advisors that add your helm hasn't been shown to help slow Alzheimer's both banana mob and add your helm. Help clear a protein called beta amyloid from the brain. I might grow CIA. The Dow gained 322 points yesterday, the S and P and the NASDAQ were up as well. I'm Rita Foley. AP News Mm hmm. This week.

Rita Foley Shelley Adler Eli Lilly Jackie Quinn Food and Drug Administration Derek Show Vin 322 points George Floyd 30 year Thursday Mexico This week FDA 272 patients AP yesterday Today Indianapolis EBS today
Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval

PM Tampa Bay with Ryan Gorman

00:21 sec | 1 year ago

Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval

"Could get cheaper price tag of $56,000 a year was set by Biogen for its treatment. But now a drug by Eli Lilly has been fast tracked by the FDA and the competition's expected to drive prices down. Word of the competition drove Biogen Stock down 6% Eli Lilly jumped 7%. Google

Biogen Eli Lilly FDA Biogen Stock Google
Will Selecta Biosciences be the Next Top Platform Biotech?

Breaking Biotech

05:38 min | 1 year ago

Will Selecta Biosciences be the Next Top Platform Biotech?

"The first company. I wanted to touch on is news from july lilly and they're huge company. Say like a large mega cap at one hundred and eighty three billion dollars and what they recently presented was the full data set from their molecule demand in alzheimer's disease. And this is a phase two trial looking at this antibody that targets a specific epoch on the amyloid beta approaching and this episode is only visible in established plaques. Now i don't want to belabor the point about the amyloid hypothesis which i've done in previous videos. Suffice to say that a number of different molecules have been attempted in this indication in specifically the mechanism of reducing amyloid plaques. And they've all failed and what we're seeing here is that in this multi center randomized double blind placebo controlled trial. That donna had a significant is what they're showing here in the air score but not a very profound impact on cognition and so they looked at this primary outcome the air score and this is a combination of the as well as the ads. Ads and so eight ask cogs general measure of cognition whereas the ads. I is a measure of activities of daily living. So they did a combined score with that and demanded mobs improvement led to a p value of point zero four so technically significant. But i'm not sure that if they replicated the stayed in a face. Three trout necessarily be positive. It is an interesting thing because when you look at the actual aid. S cog thirteen score. We don't see any significant change. It is better in indiana but not by a significant margin and then the mse score is basically no difference between the two so this is another data point to suggest that perhaps the amyloid beta hypothesis isn't one that these companies should be looking at and the last thing i wanted to show here. Is that the one thing that they do. See a significant change in the amount of amyloid in the brain and so the pet scan here to show that the dynamic treated group has a significant reduction in the amount of amyloid plaque in the brain compared to placebo. So the drug is able to reduce the emily beta plaques. But it's not able to improve cognition really as much as you would expect given the effect is there so i wanted to bring this up because there is an upcoming. Pdf date for biogen's advocating mob and this is going to be a huge movie for the stock and it was originally supposed to be in march but it was delayed until june seventh of this year. So keep your eyes on that. I don't know if i'm going to make any position on it. I think that the fda should not approve it given the results from the advisory committee but given that the so many is on this pdf. I feel like there's a chance at the fda could overlook that and end up approving drug. So it's definitely jairo word. Play and i would treat it as such and proceed likewise so that is eli lilly. I wanna quickly move on to another company in the alzheimer's face called novus and i touched on them in my previous video and what we heard in the last week was that they announced positive face to data and this is interim data showing the nbs for one or another name for the molecule is positive in improved speed and coordination in parkinson's patients. And this is a twenty five day treatment. Nine patients were in the treatment group and five or in the placebo and on the announcement of this data. I think the stock was trading around one hundred fifty maybe two hundred million dollars market valuation and went up to around two fifty three hundred before settling around two hundred and fifty million dollar market cap so big move up in the stock and i'll tell you the data. The ceo explained that the study was power to investigate a difference of twenty to twenty five percent in biomarker levels not to demonstrate efficacy making this data that much more significant so to provide some context. And why i think this is interesting. Is that i in my previous video. Didn't really seem to bullish on a novus and the reason for this is that it reminds me very closely other types of amyloid beta drugs because this drug reduces app the precursor protein to amyloid beta. So my rationale is that if they're targeting the same emily data pathway. Given that there's been so many molecules that have failed previously targeting that pathway. I don't expect that this one is going to be any different now. Having said that. I decided to take a position because we've seen over and over again. That companies have been able to spin face to data in a positive way that leads to these big increases in the sock even though in phase three there's an eventual failure so i decided to take a position in stock and i have been rewarded handsomely so far and i'm going to hold on to see the rest of the phase two data so to get the actual data here in one test that measures the speed of execution. The results were statistically significant. P equals zero point zero four showing that while parkinson's disease patients are slow in coding. Boxes met with an s four. Zero one improves their performance. In these same patients other test that measures coordination showed an improvement in their movements and was almost statistically significant peak will s- appoint zero seven. Then they say in all end. Es up tests performed the placebo group either stayed the same or performed worse than at baseline instead the a b s four zero one group either stayed the same perform better than at baseline and as we know. Md s up drs is a specific tasks that measures severity and progression of the disease.

Alzheimer's Disease Parkinson's Disease Jairo Lilly FDA Biogen Donna Indiana Eli Lilly NBS
U.S. Buys 100,000 Doses of an Eli Lilly Antibody Treatment

Dana Loesch

00:27 sec | 1 year ago

U.S. Buys 100,000 Doses of an Eli Lilly Antibody Treatment

"Notions of a treatment for Corona virus, developed by Eli Lilly are being sent to the U. S. Government. John Herrick reports the government's buying a minimum of 100,000 doses of the combination therapy. Eli Lilly CEO says the treatment greatly reduces the risk of coronavirus, hospitalizations and deaths. The government spending more than $200 million on the doses to be delivered through March 31st. They also have the option of buying an additional one million doses through November.

U. S. Government Eli Lilly John Herrick Corona Government
"eli lilly" Discussed on KUGN 590 AM

KUGN 590 AM

01:34 min | 1 year ago

"eli lilly" Discussed on KUGN 590 AM

"I haven't heard from her since Who knows? So. Meanwhile, the area has approved a new therapy from Eli Lilly. What do we know about this? There's another option, obviously, but is the Eli Lilly is that they are in a or is it the DNI to? I think this is more like Regeneron. This is a treatment like a ram desa fear. This is not a vaccine. So it's it's the monoclonal. Do you have to have it first? Before you get this? This is gonna This'd isn't a prevention. Okay, people with dementia twice as likely to get The virus more likely to be in the hospital with it. That's interesting. I did see some about that. You know, a month or so ago that dementia one of the things you get. Dementia is bad. It's kind of like if you have diabetes. It's bad. There are several things we got lung disorders as bad, Obviously. S so anyway, the numbers air really crazy, so the overall hospitalization rate was 25%, but it more than doubled. If you have dementia, 59% and then the risk of dying from it is about 5% for normal people. And if you have dementia, it's 20%. That's a huge increase. Sure is. Meanwhile, we are asking the question and people are responding. Three quarters of Americans say they're going to wear masks in public after the cove. It is no longer Ah, threat. We have a survey along that line. We get to a J. Kirshner has that info forests and other things coming up here is we continue? I want to talk about Janet Yellen. If we have a moment here after these words..

Eli Lilly Janet Yellen J. Kirshner diabetes
Report: TikTok sale pushed by Trump is shelved

WSJ Minute Briefing

00:22 sec | 1 year ago

Report: TikTok sale pushed by Trump is shelved

"We report exclusively that the plan sale of tiktok s- american operations to a group including oracle and walmart is on hold while the biden administration reviews its policies on security last year. The trump administration order to ban on tiktok and told the video sharing apps chinese owner to divest itself of its. Us operations appeal that move which is still pending in court.

Tiktok S Biden Administration Tiktok Walmart Oracle United States
Covid-19 Antibody Drug Cocktail From Eli Lilly Cleared for Use

Glenn Beck

02:16 min | 1 year ago

Covid-19 Antibody Drug Cocktail From Eli Lilly Cleared for Use

"Well, I I met Dr Heath last week. Finally in person. I've been a part of the monoclonal antibody study that u A B Did. It's medicine that was given or not given either got the placebo or the medicine from Eli Lilly. And I understand now as we were talking about this doctor this past Friday that that medicine Is now actually being given to patients that come in sick. I just missed that window of decision. And so how is that going? How are people responding? And what is that medicine? So there's a couple of different medicines that are available there. All monoclonal antibodies, which is basically just an antibody, or an immune response has been created by a drug company. And you and many other people who contributed to these studies helped us determine that in particularly high risk patients, this decreases Hospitalizations by 70%. And so when we think about all the people who have had severe disease from this virus on by numbers of people that have passed away from this virus It is really a major breakthrough of giving a treatment in the outpatient setting very early in the disease course to try toe, decrease the severity of the disease and let people have a mild or course of illness. It's my understanding is that the way the drug works is the spikes on the actual cell of the Corona virus are what causes the replication in this drug attacks that and stops replication so beyond day five or six is it too late then The Corona virus is already you know, been passed that stage and has replicated Well, we sort of think about it is the horse out of the barn yet and if we can get it into people within the first five days that is most beneficial, but were actually allowed to give it in up to the 1st 10 days. After that, 10 day point, you start to have so much inflammation in the body that giving more anti viral or antibody type medicines may not be as beneficial and so our goal is to get people diagnosed as quickly as possible, referred as quickly as possible and treated as quickly as possible before the horse gets out of the

Dr Heath Eli Lilly
"eli lilly" Discussed on WCPT 820

WCPT 820

01:37 min | 1 year ago

"eli lilly" Discussed on WCPT 820

"He's here to affirm the constitutionality of Trump's second impeachment trial proceedings will begin in earnest Wednesday at noon, with opening statements being given on each side. Florida Senator Marco Rubio says impeachment proceedings are a waste of time in Congress should be more focused on the response to the pandemic. How many people are gonna get vaccinated because of this impeachment trouble? None. How many people are going to find a job Because of this impeachment trial? None. How many people are gonna be helpful to put the kids back in school because of this impeachment trial? None. Few analysts expect 17 Republican senators to vote to convict the ex president for inciting the January 6th attack on the Capitol. President Biden's pick to lead the Office of Management and Budget is apologizing for her words on Social media. Neera Tanden had often taken aim at Republicans during her time leading a left leaning think tank. If confirmed tendon would be the first woman of color and first South Asian official to serve as the budget chief. The FDA is authorizing a new anti body drug from Eli Lilly for emergency use. The therapy uses a combination of two drugs to treat less severe cases of the Corona virus, but are at a high risk of a more serious case or hospitalization. One of the drugs involved already received authorization in November for high risk patients. California public schools may be reopening Soon Brian shook with more governor Gavin Newsom is hoping to announce the final plan this week after meeting with state lawmakers. The hang up has been whether teachers should be vaccinated against Cove in 19 before returning to the classrooms. Labor leaders have argued.

Senator Marco Rubio Neera Tanden President Biden Gavin Newsom Eli Lilly Trump Office of Management and Budge president Congress Florida Cove California FDA Brian official
"eli lilly" Discussed on WBZ NewsRadio 1030

WBZ NewsRadio 1030

04:17 min | 2 years ago

"eli lilly" Discussed on WBZ NewsRadio 1030

"In the United States. CBS News correspondent Jim Crow Sula has details. Drugmaker Eli Lilly says it's covert 19 antibody truck can prevent illness. Among residents and staff of nursing homes and other long term care facilities. Those who received the medication head up to a nearly 60% lower risk of getting coronavirus there was up to an 80% reduction in risk among nursing home residents study included nearly 1000 residents. At nursing homes from coast to coast. Itwas the deadliest outbreak ever at a long term care facility in the United States and now a committee overseeing the Holyoke soldiers home has begun efforts to make sure this tragedy never happens again. It was a catastrophic outbreak of covert 19 in the early stages of the pandemic. It led to the deaths of 76 veterans at the Holyoke Soldiers home. Health and Human Services Secretary Mary Luz Saunders told the Special Legislative Committee investigating the virus outbreak that the Holyoke soldiers home was lacking in basic structures needed to withstand the pandemic. There are many nursing homes in Massachusetts that face the pandemic, including Chelsea, but their internal structures didn't collapse and what happened at Holyoke? For my reason of everything was a complete collapse. The Legislature is studying reforms proposed by Governor Charlie Baker in the wake of the deaths at Holyoke. Mike Macklin WBZ Boston's news radio 6 48 Just about sunrise in Boston. Partly cloudy 32 degrees here in the city, saving trees in the heart of the city, a neighborhood concerned with the environmental impact of a long term construction project. Finally Convince city officials to back down on a revamp of Melania cast Boulevard. Opponents believed the proposed upgrades were not worth losing more than 100 trees. Now they've been spared. Sports betting is becoming a thing and much of the Northeast. But time and time again. Massachusetts lawmakers have kicked that can down the road. Now another try to get sports books on the books in the Commonwealth. There's no mistaking many folks are very passionate about sports, many of whom like to make a little or a lofty wager on a game or two, which legally you can't do here a matter state Senator Brendan Crichton has taken up on Beacon Hill. We have filed a pil inferred industry. That's a lot Been well in Massachusetts, but one that is unregulated and on tax. The senator's proposal allows for betting on both pro and college games, save colleges and universities on base states oil. It also provides consumer protections for responsible game and by his estimation will generate a lot of much needed cash considerably greater than 45 million annually. That initial money that we need to fight this economic crisis we're facing is a result of pandemic would be very significant. Chris Mama WBZ. Austin's NewsRadio 6 50 stocks on Wall Street are set to ends on a down note record setting week. Once again, however, Dow futures are down almost 260 points early this morning Waiver approved. The Senate is sent to confirm General Lloyd Austin as defense secretary. That confirmation is expected to come later today, also in the nation's capital, Maryland, Congressman Andy Harris Carrying a gun near the House chamber sets off a metal detector. The U. S Capitol police are now involved and now investigating prepare thy self for some binging and pillaging. Another game of Thrones. Freak Well is in the works and adaptation of Tales of Duncan Egg is in development at HBO. The show would follow the adventures of Sarah Duncan, the tall and a young egg nearly a century before the events of a song of ice and fire. You have the app, But do you have the story? She claimed her accelerator was stuck after they found her going about 115 MPH mind spotting stuck many, many I'm sorry. Let's check out the upper end of 1 28. Now with Kristen it get the whole traffic story with traffic on the three. I get stuck all the time to Laurie. I don't know how that probably busy. Boston's news radio. I like a bed that's really firm. I need something a little softer than that. Rest. Easy.

Holyoke Massachusetts Boston United States Holyoke Soldiers Sarah Duncan Eli Lilly CBS Jim Crow Sula Chris Mama WBZ Senator Brendan Crichton Governor Charlie Baker Commonwealth senator Duncan Egg Mike Macklin Mary Luz Saunders General Lloyd Austin Special Legislative Committee Legislature
"eli lilly" Discussed on WGN Radio

WGN Radio

04:27 min | 2 years ago

"eli lilly" Discussed on WGN Radio

"Focus on Day one of his first full day in office President Biden looking at the pandemic. His national strategy outlined yesterday includes increasing vaccinations and testing. By invoking the Defense Production act. Biden is also laying the groundwork for reopening schools and businesses and immediately increasing the use of masks. Masks are now required in federal buildings at airports and on planes. The goal of the administration is to vaccinate 100 million people in 100 days. Our national strategies comprehensive, it's based on science, not politics. It's based on truth, not denial. And his detail. 198 page plan is posted on the White House website. It was created with the Biden Harris administration's covert 19 Task Force, which includes Dr Anthony Fauci, who's now the White House health adviser. Health experts say 1.3 million shots a day would be needed to get every adult in America vaccinated against coronavirus. By the end of the year. Vaccinations have fallen behind early goes goals, but the numbers have been picking up. Averaging about 900,000 Day, just over a million in the last day or so. The last week's are 10 times as many doses administered than the first week vaccines became available. New anti covert drug anti body drug could help prevent the spread of covert 19 and nursing homes and other long term care facilities in a new study residents and staff who got the drug made by Eli Lilly Reduce their covert rest by 57% among nursing home residents alone. The drug, lower the risk of contracting the virus. By up to 80% experts say anybody drugs could serve as a bridge until vaccines are more widely available. The Senate impeachment trial of former President Trump could be delayed until February. Senate Minority Leader Mitch McConnell says doing so would give President Trump time to get a legal team in place and would allow the Senate to confirm or President Biden's Cabinet. House Speaker Nancy Pelosi has not said when she will transmit the article of impeachment to the Senate, according to law. Once that happens, the trial must begin within 24 hours. California Democrat Eric Swalwell says the impeachment has to go forward to future president to think that the House doesn't have the nerve to go forward with an impeachment trial. During the last few weeks of the presidency, President Trump has had a hard time finding lawyers to join his legal team. One attorney from South Carolina has signed on, but Trump is expected. Hire several more. There's no bond for a South suburban man accused of leaving a threatening voice mail for a congressman Lewis Capriati, was arrested near his Chicago Heights home earlier this month. In court yesterday, Federal prosecutors played an excerpt from the call he allegedly made last month to a member of Congress from New Jersey. The collar threatens to surround the White House and killed Democrats. Prosecutors say Capriati has a history of leaving Profane voicemails for members of Congress. Your chances of winning the $970 million Mega Millions. Jackpot are not good. Tonight's jackpot is the third largest prize in U. S history. With the one time cash payout of over $716 million. Your odds of winning it, however, are over 302 million to one. But if you do win, the experts recommend doing two things first, calling a lawyer And not telling anyone. Now, with WGN SPORTS. Here's David fourth Rank, Iowa had a chance to move back into a tie for first place in the Big 10. The Hawkeyes were 12 and 29 and no at home. Now they're nine and one after Indiana rally from nine down of the second half to hand the Hawkeyes their first loss since Christmas Day. 81 69 I was next game at Illinois a week from tonight. On the pro side. The Bulls go for three on the road tonight at Charlotte, Memphis, the latest MBA team to be shut down by the virus there next three games postponed Now their next game is against the Bulls next Wednesday. We'll see if that gets played. The Blackhawks played home tonight. Maybe that'll get him going. Hawks hosting the Detroit Red Wings the pregame on W. GM at 6 30. Patrick. My homes took the majority of snaps in practice for Kansas City Thursday, but still needs to clear concussion protocol to play Sundays. A F C championship game against Buffalo and Notre Dame's football program will spend the next year on NC double a probation. Because of recruiting violations involving a former assistant in 2019 recruiting visits will be reduced for the next year. David it w.

President Biden president Trump Senate White House Hawkeyes Lewis Capriati Bulls Congress Biden Harris David Nancy Pelosi Eli Lilly Dr Anthony Fauci Mitch McConnell America
Study: Eli Lilly's COVID-19 Antibody Protects the Most Vulnerable from Infection

Larry O'Connor

00:25 sec | 2 years ago

Study: Eli Lilly's COVID-19 Antibody Protects the Most Vulnerable from Infection

"Eli Lilly says it's Potvin 19 antibody drug, meanwhile, can prevent illness among residents and staff of nursing homes and other long term care locations. Is the first major study to show that it may prevent disease. The drug maker says participants who received the drug head up to a 57% lower risk of getting Cove it among nursing home residents. Only there was up to an 80% reduction in

Potvin Eli Lilly
Lilly: Drug can prevent COVID-19 illness in nursing homes

Wintrust Business Lunch with Steve Bertrand

00:32 sec | 2 years ago

Lilly: Drug can prevent COVID-19 illness in nursing homes

"Drugmaker Eli Lilly says it's covert 19 antibody drug can prevent illness among residents and staff of nursing homes and other long term care locations. It's the first major study to show that it may prevent disease, the drug maker, said participants who got the drug head up to a 57% lower risk of getting covert 19 among nursing home residents. Only there was up to 80% reduction in risk. US regulators last year allowed emergency use of the treatment for mild or moderate cove in 19 cases. Do not require hospitalization.

Drugmaker Eli Lilly United States
Lilly: Drug can prevent COVID-19 illness in nursing homes

AP News Radio

00:45 sec | 2 years ago

Lilly: Drug can prevent COVID-19 illness in nursing homes

"There is promising new information on a code nineteen treatment this is the first major study of Eli Lilly's cove in nineteen antibody drug treatment and those in nursing homes in November the FDA allowed emergency use of the liabilities antibody drug as a treatment for mild or moderate cases of cove it nineteen it's a one time treatment is given through an IV the company says among nursing home residents who got the drug their risk was reduced by as much as eighty percent residents and staff who got the drug had up to a fifty seven percent lower risk of getting covert nineteen nursing homes and other long term care facilities have been hit hard by the pandemic the account for nearly forty percent of the deaths I'm Rita Foley

Eli Lilly FDA Rita Foley
Dj vu in Alzheimer's research, and OWS's legacy

The Readout Loud

03:48 min | 2 years ago

Dj vu in Alzheimer's research, and OWS's legacy

"Joe biden is heading to the white house. The us is grappling with an economic crisis and biotech is debating the amyloid hypothesis. Twenty twenty. one is starting off quite a bit like two thousand nine. Thanks in part to ally lilly and some surprising data on a new treatment for alzheimer's disease the biggest story coming out of j. p. morgan this week was news that a lily drug called banana managed to significantly slowed the progression of alzheimer's in small clinical trial. So why this is so notable denham ab like so many failed drugs before it is designed to attack toxic proteins in the brain called amyloid and that was reason enough to reignite the decade plus long argument over whether clearing out amyloid can actually make a difference for patients with alzheimer's disease so before we get into the implications of all that we should summarize what we actually know. Here's what lily disclosed in a study involving two hundred and seventy two patients with early stage alzheimer's those who got to non-arab some of their cognition and function decline. At a rate that was thirty two percent slower than those who got a placebo. The company used a metric called the integrated alzheimer's disease rating scale which we should note is a different measurement than what we've seen in past trials and that's about all the detail we got so far. Lilly said it would present full data at a conference in march. But until then we've only got a press release to go off of so i. I'm curious what you guys think. What are the implications of this. All the caveats that would apply to any alzheimer study. Let alone one this small but it arrives as we await word from the fda on a different Amyloid targeting treatment from biogen called which we spent a lot of time talking about on this podcast and then here comes this lily. News like a comet from the sky. How does this change kind of the state of play of amyloid so to me. This is just it's like deja vu right. it's we sort of fall into into this pattern of just keep recycling. The same arguments about the you know the efficacy of amyloid. Whether you're drugs that target amyloid are effective in alzheimer's and i i don't know what to make of these data. I i mean. I think what it says is that we will be having this debate for years to come. Even after we get a decision on atacama. I totally agree. I mean the sense of deja vu was so strong. I was looking back at articles trying to see what had happened through the years with these drugs targeting beta amyloid and i got back to you know twenty ten. When a lily drug called sima geza stat failed and there was this great npr story actually. Quoting bob langres who at the time was at forbes announced bloomberg my old colleague saying that this was really going to call into question the amyloid hypothesis. This was eleven years ago And we had daybreak on. Cnbc this week to talk with him. He's the ceo of eli lilly. And you know. He was the first one to note. How many failures. They've had in their thirty years of working on alzheimer's disease at the company. I'm focused on on this target One thing he noted that's different about this. Trial is its size. It was small and he said that was the reason he was more optimistic about the signal. They saw that they saw such a strong signal in a small study. Made him feel like it. Had to be an even stronger signal He noted that in the past they had gone to these very large phase three trials because they thought they would have to order to see a signal and here they did this small trial to see if this was even worth pursuing a before going to that big one so i thought that was pretty interesting but i also think we're still arguing over whether amyloid is a cause of alzheimer's or like jeff jonas. The former ceo of sage. Who's still at sage in a different role You know he. He's put it as he thinks. It's more like a scar or a scab where you pull it off. That doesn't fix the underlying wound. And we just don't have those answers yet

Alzheimer's Joe Biden Denham Lilly White House Banana Sima Geza Stat Morgan Biogen Bob Langres Lily Atacama FDA United States NPR Eli Lilly Bloomberg Cnbc
"eli lilly" Discussed on Bloomberg Radio New York

Bloomberg Radio New York

06:20 min | 2 years ago

"eli lilly" Discussed on Bloomberg Radio New York

"To be be a little cautious these days. A big day for the dollar. The Bloomberg Dollars spot Index was up about a half of 1%. We've been Strengthening for about three days running here. Bloomberg Intelligence was pointing out that the move seems to be fueled by the combination of leveraged short covering along with new demand. Given the Higher Treasury yields that we're seeing today. 10 Year Treasury right now, with the yield of 1.14%, If you look at where we are at the two year, which is just 14 basis points, we've got 100 basis points now in that 2 to 10 years spread, haven't seen that for quite some time. The equity market was down from record highs today and we had the S and P being led lower by consumer, discretionary and communication services stocks on the positive side energy Was one of the big winners of the day. The S and P finished down about 7/10 of 1%. NASDAQ Calm comes in by about 1.3%, The Dow was only down about 3/10 of 1%. Now the markets in Japan will be back online at the top of the hour. We were on holiday yesterday in Tokyo. We've gotto much weaker yen here. One of 4 14. If you look at the Nikkei futures trading in Chicago, where a little bit below the cash price yesterday, or rather Friday of last week in Tokyo, so I'm going to call it a flat open right now in Sydney ASX 200 pushing higher by just three tents. Of 1% wt I crude oil holding above 50 to a barrel here in the Elektronik session. One of the big winners today in terms of the equity market stateside, Eli Lilly, the stock was up nearly 12%. Company's experimental Alzheimer's drug showing some promise after a mid stage clinical trial that is market action. We moved next to Global news on Ed Baxter from the Bloomberg 9 16 Museum in San Francisco. Eddie All right, Douglas. Mr Trump, Mr Pence have a sat down at the White House, according to a source is to Bloomberg. It was supposed to be a secret meeting s O. We don't know a whole lot about. At least it wasn't on anybody's schedule to this point, so we should or may find out more. Maybe not a little bit. Later debate and vote on suggestion of Mike Pence using the 25th amendment tomorrow in the House of Representatives, and then Wednesday Articles of impeachment and impeachment vote. President elect Joe Biden says the Senate should be able to work on impeachment and a second stimulus vaccination program and confirmations at the same time. The W H O has clearance on will land a team of experts in China this week to investigate the origins of covert 19. Tokyo New virus cases Stay over 1000 marking the seventh straight day Japanese government will declare a state of emergency for Osaka, Kyoto. He'll go prefectures as soon as tomorrow in an effort to contain The spread of the virus. And U S State Department issues a travel warning to Indonesia because of Cove. It should mention acting Homeland Secretary Chad Wolf is our resigning days after criticizing Donald Trump and Amazon warning staff of violent threats following the parlor band. In San Francisco. I'm Ed Baxter. This is Bloomberg. Brian. I got a headline for you that you obviously missed. Miss lots. Gorillas test positive for Corona virus, said San Diego Park. Oh, no, I didn't hide that. I didn't miss that. But you can have it Sure how? How that how that who gets who got close enough to guerrillas? That's amazing. Girl of my dreams. You mentioned the military parade in a North Korea, right? Young, happier is reporting that lets you stole my Japanese, um, state of emergency, Okay? Let's go to the daily mail because this one's good, too. I tipped it. Earlier, Ed. Two officers with the Capitol police suspended for joking around with rioters during the storming of the capital One took a selfie with the Trump supporter. Rather jokingly put on a mega hat. The selfie moment was posted to Twitter in a tweet now retweeted 233,000 times and liked 220,000 times. Like this one Chinese company Chow done Sports has been ordered by a court in Shanghai to stop using the name Chow Don, which is a transliteration of Michael Jordan's surname. The People's Daily reports that the court also ordered the company to stop using the former basketball star's famous number 23 combined with his name and to make it clear the brand isn't connected to Jordan in any way again. That's why Shanghai court And finally, Bloomberg reported on this and widespread media as well. UK Prime Minister Boris Johnson is now on a collision course with China. He cast dispersions on Chinese medicine and said forms of it led to the pandemic, Johnson said, using scales from the endangered pangolin to add or aid virility is demented. He said. The pandemic is the product of an imbalance in man's relationship with the natural world, right. That's a scan of the media Rashad to you. All right, well, joining his eyes Equity group template back Markets reported discussing the news of the day. And could you thank you so much for joining us? You know, we did, Of course, see the whole siege of capital die, I suppose, in some ways. We'll close it over by equity markets and other markets to there is well quite sanguine about that. But has it changed anything looking back at nearly a week since it happened? Silly. Well, thank you. For having me. A lot of risk sentiment has kind of flipped on its head is really interesting that we're talking about this pullback in the major averages today, But you really seen the lead up to it in the last few days of last week. Actually, after the Capitol speech on Wednesday, you did actually see the day that happened. Stuff ended in the green and the big question was, why is Wall Street can turning a blind eye to what going on in Washington, and it was the same day that the Senate race was confirmed in favor of Democrats. So ah lot going on in Washington. But since that moment, you start to see that yes, the stock benchmarks for ending in the green, But the NASDAQ was outperforming. Yes, 2500 and text was still outperforming small caps like glue ways. Trade was kind of flipped on its head a little bit. And that defensive trade was really taking priority, ending the day at record highs, led by Big Tech on Friday. All to turn around today..

Bloomberg Ed Baxter Bloomberg Intelligence Donald Trump San Francisco Mike Pence Senate Tokyo Boris Johnson China Washington Shanghai Alzheimer Michael Jordan House of Representatives Big Tech Eli Lilly
"eli lilly" Discussed on News Talk 1130 WISN

News Talk 1130 WISN

01:41 min | 2 years ago

"eli lilly" Discussed on News Talk 1130 WISN

"To 6 to 5 to 2 40 40 news about you and your money business report from the Koel Investment group. Good afternoon. I'm financial Advisor Ray aren't with today's final business report. The markets retreated today from the record highs of last week. In particular, social media stocks came under pressure today over concerns of heightened regulation amid actions they took to cancel several of President Trump's accounts. For example, Shares of Twitter fell 6.5% and Facebook was down 4%. Meanwhile, shares of Eli Lilly jumped over 11.5% after announcing its experimental Alzheimer's drug significantly slowed the rate of cognizant decline in patients during their face. Two trials. At the close, the Dow was down 89 points. The clothes of 31,000 and nine the S and P 500 dropped 25 in the NASDAQ closed down 166 points. This is Ray aren't with the coal all investment group visit US online at the cool wall. WeII dot com to schedule your Complementary retirement review..

Ray Koel Investment group Twitter Eli Lilly Complementary retirement revie Facebook Alzheimer Advisor Trump US President
Lilly Alzheimer's Drug Helped Patients in Small Trial

CNBC's Fast Money

01:08 min | 2 years ago

Lilly Alzheimer's Drug Helped Patients in Small Trial

"Let's check cheers of. Eli lilly topping the tape today. Rising nearly twelve percent some promising results from his alzheimer's drug metro got the details meg. Hey melissa results were surprised. This is a drug. That's face to relatively small study Early symptomatic alzheimer's disease and what they found was that this drug Helped slow the declines in cognition and function that you see with this alzheimer's disease by thirty two percent versus placebo. Now this is a drug that goes after those amyloid beta plaques in the brain the same approach we've seen the industry take over and over to no success and we should note that this is probably years from proving out to actually work and really get through the fda if it does provide in bigger trials but clearly providing a lot of hope today For the market. Anyway you also are seeing shares of biogen getting bullied on this news because they are up at the fda with their alzheimer's drug up six percent today Expecting a decision. I do kim ab march and that drug has the same mechanism of action not identical but also going after amyloid plaques smell So that was one of the big news

Alzheimer Eli Lilly Melissa FDA Alzheimer's Drug Biogen Kim Ab
Lilly Alzheimer's Drug Helped Patients in Small Trial

Glenn Beck

00:19 sec | 2 years ago

Lilly Alzheimer's Drug Helped Patients in Small Trial

"Of cases worldwide, Eli Lilly is surging before the opening bell as it's experimental. Treatment for Alzheimer's disease showed promise. In a mid stage clinical trial, Lily said that patients with early Alzheimer's who received the drug showed significant slowing of decline in a measure of cognition and daily function. Compared with

Alzheimer's Eli Lilly Lily
Doses Of Antibody Drugs Remain Unused As They Present Various Challenges

All Things Considered

03:51 min | 2 years ago

Doses Of Antibody Drugs Remain Unused As They Present Various Challenges

"The federal government says it has delivered more than 300,000 doses of monoclonal antibody drugs to help facilities nationwide. They're designed to treat patients with mild to moderate covert 19. The ideas keep those patients out of the hospital, but Many of those doses are sitting unused, due in no small part to the challenge of administering those drugs. NPR's science correspondent Richard Harris looks at to healthcare systems that have overcome those hurdles and are seeing hopeful results. Monoclonal antibodies present all sorts of challenges. They're given to people who have active infections, but who aren't hospitalized, so it's important to treat them without exposing other patients to risk. The drugs by Regeneron and Eli Lilly are also given by infusion, and that process takes a couple of hours. So when you add all this up, you know it's really a logistical challenge to deliver this therapy to a lot of people. But Dr Howard Long at Houston Methodist Hospital, says they figured out how to do that. They've opened clinics around Houston and doctors affiliated with the hospital are referring eligible patients. That is people who are over 65 or who have health conditions that put them at high risk. So at this point we're doing about 50 to 70 infusions a day, and patients are usually scheduled within a Relatively short period of time. So from the time they call into being infused, it's usually less than two days. The timing is important because these drugs appear to beam or effective early in the course of the disease. Mostly help people who aren't mounting their own strong immune reactions and, well medication sits unused in many locations around the country. That is not the case at his hospital, Hong says. Right now we're constrained more by the drug supply. They use it as fast as they get it. Any doctors nationwide aren't so enthusiastic about these drugs, though treatment guidelines issued by the National Institutes of Health say there's actually not good evidence to know whether they work. That's because the Food and Drug Administration relied on studies of just a few 100 patients to grant these drugs, emergency authorization. So these are very small numbers that under normal conditions nobody would never publish in the journal like New England Journal of Medicine. Yet this is, you know, kind of headline news. Welcome Toko bit time right. But doctors are gaining experience. Houston Methodist is now treated more than 1100 patients, Hong says. We're seeing results that are comparable to what was reported in the clinical trials by Eli Lilly and Regeneron about six or 7% of patients who are treated end up in the hospital or emergency room. He figures that without treatment about 15% of the most high risk patients could end up in the hospital or ER. Doctors affiliated with the Mayo Clinic or also encouraged by their experience. They've dust more than 2000 patients in Minnesota, Wisconsin, Arizona and Florida. Dr. Raymond reasonably has done a preliminary analysis of the 1st 1000 or so patients and finds low hospitalization rates. More importantly, there is some signal that is also reducing death. But again this our preliminary analysis we have to kind of make sure that this are all vetted by pure review. But this is what we're seeing. That's why we're happy. Unlike a clinical trial, this real world experience doesn't have a careful comparison group so doctors can't say for sure that these patients are faring better. Even so, these encouraging findings may be swaying doctors who weren't sure they wanted to refer their patients for treatment. There's nobody says patients are also becoming less skeptical. Initially, there were more declines than accept. But no, we're actually seeing more except than declines, and even though it takes a lot of person power to provide this treatment reasonably and Hong believe they're actually reducing the overall workload. Keeping patients out of the hospital. Richard Harris NPR

Regeneron Dr Howard Long Houston Methodist Hospital Eli Lilly Richard Harris NPR Houston Methodist Federal Government Hong Houston Dr. Raymond National Institutes Of Health Toko New England Journal Of Medicin Food And Drug Administration Mayo Clinic Wisconsin Minnesota
US to start distributing experimental virus drug

AP News Radio

00:53 sec | 2 years ago

US to start distributing experimental virus drug

"It's just been approved for emergency usage by the FDA now the government shipping an experimental drug the second anybody treatment for coronavirus patience health and Human Services secretary Alex a stark says the government will start distributing doses of an experimental anybody drug to fight Kobe nineteen it's the same one president trump received last month we expect to distribute about thirty thousand doses of the Regeneron product tomorrow with more to come in the ensuing weeks it's given as a one time IV treatment a coronavirus patients who are at high risk of developing serious illness Dr Janet woodcock and FDA adviser to operation warp speed says studies suggest the drug can reduce the pressure on hospital systems CBOE high risk patient had a nine percent chance of hospitalization or even death that persists three percent of treated individuals earlier this month the FDA allowed similar use of drug from Eli Lilly Jennifer king Washington

Coronavirus Patience Health An Regeneron FDA Dr Janet Woodcock Stark Kobe Alex Cboe Eli Lilly Jennifer King Washington